NEULANDLAB.NS
Price:
$13363
Market Cap:
$171.45B
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2008-10-13
Stock Exchange
NSE
Ticker
NEULANDLAB.NS
According to Neuland Laboratories Limited’s latest financial reports and current stock price. The company's current Current Ratio is 2.34. This represents a change of 108.27% compared to the average of 1.12 of the last 4 quarters.
The mean historical Current Ratio of Neuland Laboratories Limited over the last ten years is 1.46. The current 2.34 Current Ratio has changed 15.95% with respect to the historical average. Over the past ten years (40 quarters), NEULANDLAB.NS's Current Ratio was at its highest in in the September 2024 quarter at 2.34. The Current Ratio was at its lowest in in the January 2015 quarter at 0.
Average
1.46
Median
1.41
Minimum
1.07
Maximum
2.15
Discovering the peaks and valleys of Neuland Laboratories Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 24.24%
Maximum Annual Current Ratio = 2.15
Minimum Annual Increase = -7.19%
Minimum Annual Current Ratio = 1.07
Year | Current Ratio | Change |
---|---|---|
2024 | 2.15 | 24.24% |
2023 | 1.73 | 8.39% |
2022 | 1.60 | 7.24% |
2021 | 1.49 | 3.53% |
2020 | 1.44 | 3.87% |
2019 | 1.39 | 13.79% |
2018 | 1.22 | -7.19% |
2017 | 1.31 | 12.02% |
2016 | 1.17 | 9.58% |
2015 | 1.07 | 8.67% |
The current Current Ratio of Neuland Laboratories Limited (NEULANDLAB.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.83
5-year avg
1.68
10-year avg
1.46
Neuland Laboratories Limited’s Current Ratio is
Company | Current Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neuland Laboratories Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Neuland Laboratories Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Neuland Laboratories Limited's Current Ratio?
How is the Current Ratio calculated for Neuland Laboratories Limited (NEULANDLAB.NS)?
What is the highest Current Ratio for Neuland Laboratories Limited (NEULANDLAB.NS)?
What is the 3-year average Current Ratio for Neuland Laboratories Limited (NEULANDLAB.NS)?
What is the 5-year average Current Ratio for Neuland Laboratories Limited (NEULANDLAB.NS)?
How does the current Current Ratio for Neuland Laboratories Limited (NEULANDLAB.NS) compare to its historical average?